BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schölvinck D, Künzli H, Meijer S, Seldenrijk K, van Berge Henegouwen M, Bergman J, Weusten B. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc. 2016;30:4102-4113. [PMID: 27357927 DOI: 10.1007/s00464-016-5071-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Kahn A, Kamboj AK, Muppa P, Sawas T, Lutzke LS, Buras MR, Golafshar MA, Katzka DA, Iyer PG, Smyrk TC, Wang KK, Leggett CL. Staging of T1 esophageal adenocarcinoma with volumetric laser endomicroscopy: a feasibility study.Endosc Int Open. 2019;7:E462-E470. [PMID: 30931378 DOI: 10.1055/a-0838-5326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Belghazi K, Pouw RE, Bergman JJ. In the expanding arena of endoscopic management for Barrett's neoplasia, how should we fit in endoscopic submucosal dissection? Gastrointest Endosc 2018;87:1394-5. [PMID: 29759155 DOI: 10.1016/j.gie.2018.02.004] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Seewald S, Ang TL, Pouw RE, Bannwart F, Bergman JJ. Management of Early-Stage Adenocarcinoma of the Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Dig Dis Sci 2018;63:2146-54. [PMID: 29934725 DOI: 10.1007/s10620-018-5158-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Braun S, Ell C, Lorenz D. Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma. World J Surg. 2020;44:1192-1199. [PMID: 31853591 DOI: 10.1007/s00268-019-05291-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Saunders JH, Al-Zubaidi S, Waller RC, Ortiz-Fernandez-Sordo J, Parsons SL, Ragunath K, Kaye PV; Trent Oesophago-Gastric Unit. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma. Dis Esophagus 2020;33:doz097. [PMID: 32090253 DOI: 10.1093/dote/doz097] [Reference Citation Analysis]
6 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Fisseler-Eckhoff A, Braun S, Ell C, Lorenz D. The overall metastatic rate in early esophageal adenocarcinoma: long-time follow-up of surgically treated patients. Dis Esophagus 2019;32:doy127. [PMID: 30596900 DOI: 10.1093/dote/doy127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Künzli HT, Belghazi K, Pouw RE, Meijer SL, Seldenrijk CA, Weusten B, Bergman J. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma. United European Gastroenterol J 2018;6:669-77. [PMID: 30083328 DOI: 10.1177/2050640617753808] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
9 Dunn JM, Reyhani A, Santaolalla A, Zylstra J, Gimson E, Pennington M, Baker C, Kelly M, Van Hemelrijck M, Lagergren J, Zeki SS, Gossage JA, Davies AR. Transition from esophagectomy to endoscopic therapy for early esophageal cancer. Dis Esophagus 2021:doab047. [PMID: 34260693 DOI: 10.1093/dote/doab047] [Reference Citation Analysis]
10 Gotink AW, van de Ven SEM, Ten Kate FJC, Nieboer D, Suzuki L, Weusten BLAM, Brosens LAA, van Hillegersberg R, Alvarez Herrero L, Seldenrijk CA, Alkhalaf A, Moll FCP, Schoon EJ, van Lijnschoten I, Tang TJ, van der Valk H, Nagengast WB, Kats-Ugurlu G, Plukker JTM, Houben MHMG, van der Laan JS, Pouw RE, Bergman JJGHM, Meijer SL, van Berge Henegouwen MI, Wijnhoven BPL, de Jonge PJF, Doukas M, Bruno MJ, Biermann K, Koch AD. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Endoscopy 2021. [PMID: 33626582 DOI: 10.1055/a-1399-4989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jansen M. Histopathology-led quality evaluation of endoluminal excision specimens - not a bad idea! Endoscopy 2021. [PMID: 34905791 DOI: 10.1055/a-1656-9640] [Reference Citation Analysis]
12 Ballard DD, Choksi N, Lin J, Choi EY, Elmunzer BJ, Appelman H, Rex DK, Fatima H, Kessler W, DeWitt JM. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection. World J Gastrointest Endosc 2016; 8(20): 763-769 [PMID: 28042390 DOI: 10.4253/wjge.v8.i20.763] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Otaki F, Ma GK, Krigel A, Dierkhising RA, Lewis JT, Blevins CH, Gopalakrishnan NP, Ravindran A, Johnson ML, Leggett CL, Wigle D, Wang KK, Falk GW, Abrams JA, Nakagawa H, Rustgi AK, Wang TC, Lightdale CJ, Ginsberg GG, Iyer PG. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Gastrointest Endosc 2020;92:31-39.e1. [PMID: 31953189 DOI: 10.1016/j.gie.2020.01.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
14 di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154:421-436. [PMID: 28778650 DOI: 10.1053/j.gastro.2017.07.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
15 Nieuwenhuis EA, Pech O, Bergman JJGHM, Pouw RE. Role of Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection in the Management of Barrett's Related Neoplasia. Gastrointest Endosc Clin N Am 2021;31:171-82. [PMID: 33213794 DOI: 10.1016/j.giec.2020.09.001] [Reference Citation Analysis]
16 Noordzij IC, Curvers WL, Schoon EJ. Endoscopic resection for early esophageal carcinoma. J Thorac Dis 2019;11:S713-22. [PMID: 31080649 DOI: 10.21037/jtd.2019.03.19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
17 Chen B, Lin J, Ruan Y, Chen Z, Petersen K, Kong M, Shen J, Wang G. The influence of adjuvant radiation therapy after endoscopic resection on survival for early stage EC: an analysis of the surveillance epidemiology and end results (SEER) database. J Thorac Dis 2019;11:3427-34. [PMID: 31559047 DOI: 10.21037/jtd.2019.07.78] [Reference Citation Analysis]
18 Karamchandani DM, Gonzalez RS, Westerhoff M, Westbrook LM, Panarelli NC, Al-Nuaimi M, King T, Arnold CA. Measuring depth of invasion of submucosa - invasive adenocarcinoma in oesophageal endoscopic specimens: how good are we?☆. Histopathology 2021. [PMID: 34519098 DOI: 10.1111/his.14566] [Reference Citation Analysis]
19 Sanghi V, Amin H, Sanaka MR, Thota PN. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management. World J Gastrointest Endosc 2019; 11(10): 491-503 [PMID: 31798770 DOI: 10.4253/wjge.v11.i10.491] [Reference Citation Analysis]
20 Friedland S, Triadafilopoulos G. Can endoscopic resection for Barrett's dysplasia and early cancer be curative? Ann N Y Acad Sci. 2018;1434:54-58. [PMID: 29752721 DOI: 10.1111/nyas.13715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20:71. [PMID: 30058019 DOI: 10.1007/s11912-018-0713-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
22 Kumble LD, Silver E, Oh A, Abrams JA, Sonett JR, Hur C. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World J Meta-Anal 2019; 7(9): 406-417 [DOI: 10.13105/wjma.v7.i9.406] [Reference Citation Analysis]
23 Watts AE, Cotton CC, Shaheen NJ. Radiofrequency Ablation of Barrett's Esophagus: Have We Gone Too Far, or Not Far Enough? Curr Gastroenterol Rep 2020;22:29. [PMID: 32383077 DOI: 10.1007/s11894-020-00766-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Overwater A, Weusten BLAM, Ruurda JP, van Hillegersberg R, Bennink RJ, de Keizer B, Meijer SL, Brosens LAA, Pouw RE, Bergman JJGHM, van Berge Henegouwen MI, Gisbertz SS. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green. Surg Endosc 2021. [PMID: 34046715 DOI: 10.1007/s00464-021-08551-6] [Reference Citation Analysis]
25 Wang W, Chen D, Sang Y, Chen C, Zhang Y, Mao Y, Chen Y. Endoscopic resection versus esophagectomy for patients with small-sized T1N0 esophageal cancer: A propensity-matched study. Clin Res Hepatol Gastroenterol 2021;45:101543. [PMID: 33554864 DOI: 10.1016/j.clinre.2020.09.004] [Reference Citation Analysis]
26 Alzoubaidi D, Ragunath K, Wani S, Penman ID, Trudgill NJ, Jansen M, Banks M, Bhandari P, Morris AJ, Willert R, Boger P, Smart HL, Ravi N, Dunn J, Gordon C, Mannath J, Mainie I, di Pietro M, Veitch AM, Thorpe S, Magee C, Everson M, Sami S, Bassett P, Graham D, Attwood S, Pech O, Sharma P, Lovat LB, Haidry R. Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia. Frontline Gastroenterol 2020;11:259-71. [PMID: 32587669 DOI: 10.1136/flgastro-2019-101247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Borggreve AS, Kingma BF, Domrachev SA, Koshkin MA, Ruurda JP, Hillegersberg R, Takeda FR, Goense L. Surgical treatment of esophageal cancer in the era of multimodality management. Ann N Y Acad Sci 2018;1434:192-209. [DOI: 10.1111/nyas.13677] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
28 Otaki F, Iyer PG. Response. Gastrointest Endosc 2021;93:283-4. [PMID: 33353635 DOI: 10.1016/j.gie.2020.09.015] [Reference Citation Analysis]
29 Leclercq P, Bisschops R. Optimizing Outcomes with Radiofrequency Ablation of Barrett's Esophagus: Candidates, Efficacy and Durability. Gastrointest Endosc Clin N Am 2021;31:131-54. [PMID: 33213792 DOI: 10.1016/j.giec.2020.09.004] [Reference Citation Analysis]
30 Belghazi K, Bergman JJGHM, Pouw RE. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Gastrointest Endosc Clin N Am 2017;27:461-70. [PMID: 28577767 DOI: 10.1016/j.giec.2017.02.004] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
31 Dermine S, Leconte M, Leblanc S, Dousset B, Terris B, Berger A, Berger A, Rahmi G, Lepilliez V, Plomteux O, Leclercq P, Coriat R, Chaussade S, Prat F, Barret M. Outcomes of esophagectomy after noncurative endoscopic resection of early esophageal cancer. Therap Adv Gastroenterol. 2019;12:1756284819892556. [PMID: 31839807 DOI: 10.1177/1756284819892556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Künzli HT, van Berge Henegouwen MI, Gisbertz SS, van Esser S, Meijer SL, Bennink RJ, Wiezer MJ, Seldenrijk CA, Bergman JJGHM, Weusten BLAM. Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients. Dis Esophagus 2017;30:1-8. [PMID: 28881907 DOI: 10.1093/dote/dox097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
33 Sehgal V, Ragunath K, Haidry R. Measuring Quality in Barrett's Esophagus: Time to Embrace Quality Indicators. Gastrointest Endosc Clin N Am 2021;31:219-36. [PMID: 33213797 DOI: 10.1016/j.giec.2020.09.006] [Reference Citation Analysis]
34 Tan WK, di Pietro M, Fitzgerald RC. Past, present and future of Barrett's oesophagus. Eur J Surg Oncol 2017;43:1148-60. [PMID: 28256346 DOI: 10.1016/j.ejso.2017.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
35 Duprée A, Ehlken H, Rösch T, Lüken M, Reeh M, Werner YB, de Heer J, Schachschal G, Clauditz TS, Mann O, Izbicki JR, Groth S. Laparoscopic lymph node sampling: a new concept for patients with high-risk early esophagogastric junction cancer resected endoscopically. Gastrointest Endosc 2021;94:282-90. [PMID: 33639136 DOI: 10.1016/j.gie.2021.02.014] [Reference Citation Analysis]
36 Yang H, Hu B. Recent advances in early esophageal cancer: diagnosis and treatment based on endoscopy. Postgrad Med 2021;133:665-73. [PMID: 34030580 DOI: 10.1080/00325481.2021.1934495] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Gotink AW, Ten Kate FJ, Doukas M, Wijnhoven BP, Bruno MJ, Looijenga LH, Koch AD, Biermann K. Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma? United European Gastroenterol J 2019;7:261-9. [PMID: 31080611 DOI: 10.1177/2050640618817693] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]